11/9
09:50 am
prqr
ProQR Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
High
Report
ProQR Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
11/7
07:00 am
prqr
ProQR Announces Third Quarter 2024 Operating and Financial Results
Low
Report
ProQR Announces Third Quarter 2024 Operating and Financial Results
10/29
09:02 am
prqr
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $14.00 price target on the stock, up previously from $6.00.
Medium
Report
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $14.00 price target on the stock, up previously from $6.00.
10/25
04:50 pm
prqr
ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement [Yahoo! Finance]
Medium
Report
ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement [Yahoo! Finance]
10/25
04:45 pm
prqr
ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement
Medium
Report
ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement
10/22
10:19 pm
prqr
ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement [Yahoo! Finance]
Medium
Report
ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement [Yahoo! Finance]
10/22
10:15 pm
prqr
ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement
Medium
Report
ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement
10/22
04:01 pm
prqr
ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares
Medium
Report
ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares
10/20
08:57 am
prqr
ProQR Therapeutics (NASDAQ:PRQR) shareholder returns have been solid, earning 231% in 1 year [Yahoo! Finance]
Medium
Report
ProQR Therapeutics (NASDAQ:PRQR) shareholder returns have been solid, earning 231% in 1 year [Yahoo! Finance]
10/7
08:00 am
prqr
ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society
Low
Report
ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society
9/10
04:30 pm
prqr
ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference
Low
Report
ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference